Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Comparison of conventional transarterial chemoembolization (cTACE) with doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: HUA, Shih-Chun (Cathay General Hospital, Taipei, China Taiwan)
  • Co-author(s): Wu, Shwu-Ying (Cathay General Hospital, Taipei, China Taiwan)
    Huang, Wan-Tsui (Cathay General Hospital, Taipei, China Taiwan)
  • Abstract:


    Background



    Transarterial chemoembolization (TACE) has been the main treatment for unresectable hepatocellular carcinoma (HCC). Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) is a newly developed treatment to improve drug delivery with lower systemic toxicity.


    Aims



    This retrospective study aimed to compare the outcomes

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses